Wen-Ho Chang, MD

Original Research

Equivalent Switching Dose From Oral Risperidone to Risperidone Long-Acting Injection: A 48-Week Randomized, Prospective, Single-Blind Pharmacokinetic Study

August 15, 2007

Original Research

Adjunctive Fluvoxamine Inhibits Clozapine-Related Weight Gain and Metabolic Disturbances

June 1, 2004

Original Research

Effects of Patient Demographics, Risperidone Dosage, and Clinical Outcome on Body Weight in Acutely Exacerbated Schizophrenia

March 15, 2003

Letter to the Editor

A Pilot Double-Blind, Dose-Comparison Study of Risperidone in Drug-Naive, First-Episode Schizophrenia

November 1, 2001

Original Research

Repeated Ingestion of Grapefruit Juice Does Not Alter Clozapine's Steady-State Plasma Levels, Effectiveness, and Tolerability

October 1, 2001

Original Research

Fluvoxamine Reduces the Clozapine Dosage Needed in Refractory Schizophrenic Patients

August 31, 2000

Original Research

Risperidone in Acutely Exacerbated Schizophrenia: Dosing Strategies and Plasma Levels

August 31, 2000

Letter to the Editor

Clozapine Versus Risperidone in Treatment-Refractory Schizophrenia: Possible Impact of Dosing Strategies

July 1, 1999

Letter to the Editor

Seizures After Discontinuation of Low-Dose Lorazepam From Originally Seizure-Free Clozapine Regimen: Combined Effects?

June 30, 1999

Original Research

Effects of Gender and Age on Plasma Levels of Clozapine and Its Metabolites: Analyzed by Critical Statistics

January 31, 1999

Letter to the Editor

Manic and Psychotic Symptoms Following Risperidone Withdrawal in a Schizophrenic Patient

November 15, 1998

Letter to the Editor

Risperidone Monotherapy for Psychotic Depression Unresponsive to Other Treatments

November 15, 1998